Skip to main content

Roche Licenses NuGen Technology for RNA Amplification Kit

NEW YORK (GenomeWeb News) – Roche announced today that it has licensed technology from NuGen Technologies that will be included in Roche’s LightCycler RNA Pre-Amplification Kit, which will be launched in the third quarter of 2008.
 
Under the co-exclusive agreement, NuGen will supply components for the kit and has provided Roche with limited access to NuGen’s Ovation technology, which enables small and partially degraded RNA samples to be amplified into micrograms of cDNA.
 
The new LightCycler Kit will allow researchers to conduct whole-transcriptome gene expression analysis of challenging clinical samples, Roche said in a statement. The firm believes NuGen’s whole-transcriptome RNA amplification methodology will provide it with an advantage over competitors by enabling high-throughput, multi-test real-time PCR assays that have a quicker time to result.
 
Elizabeth Hutt, CEO of San Carlos, Calif.-based NuGen said that Roche’s use of the Ovation technology “is an important validation of the precision of our RNA amplification technology.”
 
Financial terms of the deal were not disclosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.